Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Antiretroviral Drug Resistance Surveillance among Treatment-Naive Human Immunodeficiency Virus Type 1-Infected Individuals in Angola: Evidence for Low Level of Transmitted Drug Resistance
Antimicrobial Agents and Chemotherapy, 06/29/09
Bártolo I et al. - Numerous new polymorphisms were identified in the reverse transcriptase and protease. Two unrelated patients harbored nucleoside reverse transcriptase inhibitor- and nonnucleoside reverse transcriptase inhibitor-resistant viruses. Continued surveillance of drug resistance is required for maximization of ART efficacy in Angola.
Nuno Taveira, 06/30/09
| Transmission of drug resistant HIV-1 strains may compromise the efficacy of antiretroviral therapy (ART) especially in developing countries with limited access to second-line regimens. We found that primary resistance to ART was residual (<5%) in Luanda, Angola, in 2001. Of note, however, two untreated patients were infected with drug resistant variants even though access to ART was still not generalized in Angola in 2001. In recent years ART has been made available to a greater number of patients in Angola. To avoid further transmission of drug resistant strains and to be able to offer the most successful therapeutic regimens in Angola, it is important to implement drug resistance surveillance systems in Angola and perform regular studies of drug resistance in treated and untreated patients. We are doing a follow-up study of primary resistance to ART in untreated HIV-1 patients from Luanda with samples collected in 2008. Preliminary results indicate that in 2008 primary resistance to ART was still residual (1 case in 19 patients studied so far). Pending the analysis of more patients, these results suggest that transmission of drug resistant HIV-1 variants will not be a major problem in Angola. |
Related Articles
Prevalence and Correlates of Elevated Body Mass Index among HIV-Positive and HIV-Negative Women in the Womens Interagency HIV Study
AIDS Patient Care and STDs, 11/19/09
Relevance Score: 95%
Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09
Relevance Score: 95%
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Relevance Score: 95%
War and Peace between Microbes: HIV-1 Interactions with Coinfecting Viruses
Cell Host & Microbe, 11/23/09
Relevance Score: 94%
Mediators of HIV-related stigma and risk behavior in HIV infected young women
AIDS Care, 11/12/09
Relevance Score: 94%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent
BMC: Journal of Biomedical Science, 12/10/09
Accumulation of CD11b+ Lung Dendritic Cells in Response to Fungal Infection Results from the CCR2-Mediated Recruitment and Differentiation of Ly-6Chigh Monocytes
Journal of Immunology, 12/10/09
Cytolethal Distending Toxin from Aggregatibacter actinomycetemcomitans induces DNA damage, S/G2 cell cycle arrest and caspase-independent death in budding yeast model
Infection and Immunity, 12/10/09
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
The effect of a basic home stimulation programme on the development of young children infected with HIV
Developmental Medicine & Child Neurology, 12/10/09
Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden
American Journal of Epidemiology, 12/10/09
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
BMC Infectious Diseases, 12/10/09
Article Search
Sponsor


See Latest Articles


